Breaking News Instant updates and real-time market news.

MON

Monsanto

$117.29

0.19 (0.16%)

, SYT

Syngenta

$92.76

0.2 (0.22%)

09:52
07/17/17
07/17
09:52
07/17/17
09:52

EU to extend glyphosate approval with national backing, Reuters reports

European Health and Food Safety Commissioner Vytenis Andriukaitis says that the EU will extend its approval for glyphosate only if there is enough support from the 28 member states, Reuters reports. Concerns over the herbicide's risk to human health have prompted investigations by U.S. congressional committees and delayed a relicensing decision in Europe for Monsanto's Roundup weed killer. Andriukaitis says that while he has no reason to doubt the safety of glyphosate, "I wanted to make clear that the Commission has no intention to reapprove this substance without the support of a qualified majority of member states. This is and will remain a shared responsibility." Reference Link

MON

Monsanto

$117.29

0.19 (0.16%)

SYT

Syngenta

$92.76

0.2 (0.22%)

DD

Changed to DWDP

$84.62

-0.13 (-0.15%)

DOW

Changed to DWDP

$66.22

-0.02 (-0.03%)

BASFY

BASF

$96.23

1.67 (1.77%)

  • 25

    Jul

MON Monsanto
$117.29

0.19 (0.16%)

06/27/17
SUSQ
06/27/17
DOWNGRADE
SUSQ
Neutral
Monsanto downgraded to Neutral from Positive at Susquehanna
04/06/17
JPMS
04/06/17
NO CHANGE
Target $128
JPMS
Overweight
Monsanto shares offer 'excellent' risk/reward proposition, says JPMorgan
JPMorgan analyst Jeffrey Zekauskas says shares of Monsanto (MON) at current levels offer an "excellent" risk/reward proposition. The analyst views capital appreciation potential to the end of 2017 as 11% or a 15% annual return. He sees downside risk of only 3%, to $112 per share, in the event that Bayer (BAYRY) is not able to consummate the acquisition. Zekauskas has increased confidence in the deal closing following recent regulatory rulings and keeps an Overweight rating on the name with a $128 price target.
06/27/17
SUSQ
06/27/17
DOWNGRADE
Target $128
SUSQ
Neutral
Monsanto downgraded to Neutral at Susquehanna
As previously reported, Susquehanna analyst Don Carson downgraded Monsanto (MON) to Neutral from Positive. The downgrade reflects the 9% upside to the $128 price target offer from Bayer (BAYRY), which is less than the firm's 15% threshold for a Positive rating. The companies expects the deal to close by calendar year-end 2017.
03/03/17
JPMS
03/03/17
NO CHANGE
Target $128
JPMS
Overweight
EU approvals of other ag deals may narrow Monsanto deal spread, says JPMorgan
JPMorgan analyst Jeffrey Zekauskas said commentary from the CEOs of DuPont (DD) and Syngenta (SYT) and press reports from Europe suggest that their deals with Dow Chemical (DOW) and ChemChina, respectively, are likely to be approved. Approvals from Europe for those deals may "trigger a meaningful closing of the arbitrage spread" in Monsanto (MON) shares versus Bayer's (BAYRY) offer price, Zekauskas tells investors. He recommends buying Monsanto shares at current levels for this reason, adding that he believes the shares would only fall about 2.5%, or down to $112, in the event of the Bayer deal falling through. Zekauskas keeps an Overweight rating and $128 price target on Monsanto shares, which closed yesterday at just below $115 per share.
SYT Syngenta
$92.76

0.2 (0.22%)

09/06/16
BERN
09/06/16
DOWNGRADE
BERN
Market Perform
Syngenta downgraded on valuation, anticipated deal delay at Bernstein
As noted earlier, Bernstein downgraded Syngenta to Market Perform from Outperform. As reasons for the downgrade, analyst Jeremy Redenius cited valuation and his belief that regulatory approvals for the company's acquisition by ChemChina could be delayed until 2017. Target to $92.20 from $90.20.
12/09/16
RAJA
12/09/16
UPGRADE
RAJA
Strong Buy
Syngenta upgraded to Strong Buy from Outperform at Raymond James
Raymond James analyst Patrick Lambert upgraded Syngenta to Strong Buy.
02/16/17
JEFF
02/16/17
DOWNGRADE
JEFF
Hold
Syngenta downgraded to Hold from Buy at Jefferies
Jefferies analyst Laurence Alexander downgraded Syngenta to Hold with an unchanged price target of CHF 445.
DD Changed to DWDP
$84.62

-0.13 (-0.15%)

03/06/17
JEFF
03/06/17
UPGRADE
Target $96
JEFF
Buy
DuPont upgraded to Buy from Hold at Jefferies
Jefferies analyst Laurence Alexander upgraded DuPont (DD) to Buy and raised his price target for the shares to $96 from $83. The analyst believes the merger with Dow Chemical (DOW) is likely to close in the near future and that only "cautious enthusiasm" is being priced into the shares. Capitalizing on the targeted cost synergies implies 11%-17% potential upside in the stocks, Alexander tells investors in a research note. The analyst this morning also upgraded Dow Chemical to Buy.
04/03/17
FBCO
04/03/17
NO CHANGE
Target $77
FBCO
Outperform
FMC Corporation price target raised to $77 from $65 at Credit Suisse
Credit Suisse analyst Christopher Parkinson raised his price target for FMC Corporation (FMC) to $77 from $65 after the company announced the acquisition of significant crop protection assets from DuPont (DD). The analyst views the acquisition accretive upon close and with synergy upside potential. He reiterates an Outperform rating on FMC Corporation's shares.
04/03/17
SUSQ
04/03/17
UPGRADE
Target $86
SUSQ
Positive
FMC Corporation upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst Donald Carson upgraded FMC Corporation (FMC) to Positive from Neutral citing the acquisition of DuPont's (DD) insecticide portfolio and cereal herbicide portfolio, which along with its supporting R&D and pipeline programs transforms FMC into one of the five global innovators in crop protection chemicals. Carson raised his price target to $86 from $62 on FMC Corp. shares.
04/26/17
FBCO
04/26/17
NO CHANGE
Target $87
FBCO
Neutral
DuPont price target raised to $87 from $76 at Credit Suisse
Credit Suisse analyst Christopher Parkinson raised his price target for DuPont to $87 from $76 after "solid" cost-cutting execution and better volumes drove a Q1 beat. The analyst reiterates a Neutral rating on the shares.
DOW Changed to DWDP
$66.22

-0.02 (-0.03%)

01/27/17
FBCO
01/27/17
NO CHANGE
Target $66
FBCO
Outperform
Dow Chemical price target raised to $66 from $61 at Credit Suisse
Credit Suisse analyst Christopher Parkinson raised his price target for Dow Chemical to $66 from $61 as "strong" fundamentals and cost-cutting execution drove a Q4 beat. Heading into 2017, the analyst is encouraged by the company's ability to drive profit growth through ongoing cost-cutting initiatives, streamlined execution of Dow Corning cost synergies and a timely ramp of the project backlog, which should more than offset some risk regarding a volatile macro and FX. He reiterates an Outperform rating on the shares.
03/06/17
JEFF
03/06/17
UPGRADE
Target $75
JEFF
Buy
Dow Chemical upgraded to Buy from Hold at Jefferies
Jefferies analyst Laurence Alexander upgraded Dow Chemical (DOW) to Buy and raised his price target for the shares to $75 from $65. The analyst believes the merger with DuPont (DD) is likely to close in the near future and that only "cautious enthusiasm" is being priced into the shares. Capitalizing on the targeted cost synergies implies 11%-17% potential upside in the stocks, Alexander tells investors in a research note.
BASFY BASF
$96.23

1.67 (1.77%)

02/13/17
EVER
02/13/17
INITIATION
EVER
Buy
BASF initiated with a Buy at Evercore ISI
Evercore ISI analyst Laurent Favre initiated BASF with a Buy rating and a EUR100 price target.
01/19/17
JPMS
01/19/17
UPGRADE
JPMS
Overweight
BASF upgraded to Overweight from Underweight at JPMorgan
JPMorgan analyst Martin Evans yesterday double upgraded BASF to Overweight from Underweight saying he's turning more positive on European Chemicals.
10/05/16
UBSW
10/05/16
UPGRADE
UBSW
Buy
BASF upgraded to Buy from Neutral at UBS

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.